Peter R Donald Selected Research

Aminosalicylic Acid (Rezipas)

1/2022	Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
11/2020	Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens.
1/2020	Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
9/2015	Para-aminosalicylic acid: the return of an old friend.
7/2015	N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.
10/2014	Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
4/2014	Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter R Donald Research Topics

Disease

24	Tuberculosis (Tuberculoses) 01/2022 - 05/2006
11	Pulmonary Tuberculosis 12/2015 - 07/2005
8	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2020 - 05/2006
4	Infections 01/2022 - 05/2002
3	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2016 - 03/2014
3	HIV Infections (HIV Infection) 10/2014 - 11/2007
2	Extensively Drug-Resistant Tuberculosis 10/2014 - 08/2009
2	Body Weight (Weight, Body) 06/2012 - 06/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Vaccine-Preventable Diseases 01/2022
1	Bovine Tuberculosis 01/2022
1	Diarrhea 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Ventricular Tachycardia 05/2015
1	Hepatitis 03/2014
1	Jaundice (Icterus) 06/2011
1	Thrombosis (Thrombus) 09/2009
1	Kwashiorkor 06/2009
1	Reinfection 08/2005

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2020 - 08/2005
10	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 07/2005
7	Aminosalicylic Acid (Rezipas)FDA Link 01/2022 - 04/2014
7	Isoniazid (Ftivazide)FDA LinkGeneric 05/2015 - 05/2006
4	Pyrazinamide FDA LinkGeneric 05/2015 - 01/2012
4	pretomanidIBA 05/2015 - 08/2010
2	Streptomycin (Streptomycin Sulfate)FDA Link 09/2015 - 01/2012
2	Ethambutol (Myambutol)FDA LinkGeneric 05/2015 - 01/2012
2	bedaquiline (R207910)IBA 04/2015 - 05/2013
1	VaccinesIBA 01/2022
1	Attenuated VaccinesIBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	AcidsIBA 12/2015
1	LipidsIBA 12/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2015
1	N- geranyl- N'- (2- adamantyl)ethane- 1,2- diamineIBA 12/2015
1	AcetyltransferasesIBA 07/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	Moxifloxacin (Avelox)FDA Link 05/2015
1	Clofazimine (Lamprene)FDA Link 04/2015
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2012
1	Phenobarbital (Luminal)FDA Link 09/2009
1	Linezolid (Zyvox)FDA Link 08/2009
1	rifapentine (Priftin)FDA Link 07/2005

Therapy/Procedure

6	Therapeutics 10/2014 - 10/2006
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2012
3	Chemoprevention 06/2011 - 05/2002
1	Heliotherapy 01/2012